Literature DB >> 19461045

Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.

Soo-Ho Choi1, Richard Harkewicz, Jee Hyun Lee, Agnès Boullier, Felicidad Almazan, Andrew C Li, Joseph L Witztum, Yun Soo Bae, Yury I Miller.   

Abstract

Toll-like receptor (TLR)4 recognizes microbial pathogens, such as lipopolysaccharide, and mediates lipopolysaccharide-induced proinflammatory cytokine secretion, as well as microbial uptake by macrophages. In addition to exogenous pathogens, TLR4 recognizes modified self, such as minimally oxidized low-density lipoprotein (mmLDL). Here we report that mmLDL and its active components, cholesteryl ester hydroperoxides, induce TLR4-dependent fluid phase uptake typical of macropinocytosis. We show that mmLDL induced recruitment of spleen tyrosine kinase (Syk) to a TLR4 signaling complex, TLR4 phosphorylation, activation of a Vav1-Ras-Raf-MEK-ERK1/2 signaling cascade, phosphorylation of paxillin, and activation of Rac, Cdc42, and Rho. These mmLDL-induced and TLR4- and Syk-dependent signaling events and cytoskeletal rearrangements lead to enhanced uptake of small molecules, dextran, and, most importantly, both native and oxidized LDL, resulting in intracellular lipid accumulation. An intravenous injection of fluorescently labeled mmLDL in wild-type mice resulted in its rapid accumulation in circulating monocytes, which was significantly attenuated in TLR4-deficient mice. These data describe a novel mechanism leading to enhanced lipoprotein uptake in macrophages that would contribute to foam cell formation and atherosclerosis. These data also suggest that cholesteryl ester hydroperoxides are an endogenous ligand for TLR4. Because TLR4 is highly expressed on the surface of circulating monocytes in patients with chronic inflammatory conditions, and cholesteryl ester hydroperoxides are present in plasma, lipid uptake by monocytes in circulation may contribute to the pathological roles of monocytes in chronic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461045      PMCID: PMC2741301          DOI: 10.1161/CIRCRESAHA.108.192880

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

Review 1.  Scavenger receptors, oxidized LDL, and atherosclerosis.

Authors:  A Boullier; D A Bird; M K Chang; E A Dennis; P Friedman; K Gillotre-Taylor; S Hörkkö; W Palinski; O Quehenberger; P Shaw; D Steinberg; V Terpstra; J L Witztum
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  Tyrosine kinase Syk associates with toll-like receptor 4 and regulates signaling in human monocytic cells.

Authors:  Anu Chaudhary; Theresa M Fresquez; Michele J Naranjo
Journal:  Immunol Cell Biol       Date:  2007-01-16       Impact factor: 5.126

Review 3.  Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.

Authors:  Ira Tabas; Kevin Jon Williams; Jan Borén
Journal:  Circulation       Date:  2007-10-16       Impact factor: 29.690

4.  Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.

Authors:  Yury I Miller; Suganya Viriyakosol; Dorothy S Worrall; Agnès Boullier; Susan Butler; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-17       Impact factor: 8.311

Review 5.  Fate of lipid hydroperoxides in blood plasma.

Authors:  Y Yamamoto
Journal:  Free Radic Res       Date:  2000-12

6.  Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome.

Authors:  Heiko Methe; Jong-Oh Kim; Sieglinde Kofler; Michael Weis; Michael Nabauer; Joerg Koglin
Journal:  Circulation       Date:  2005-05-09       Impact factor: 29.690

7.  Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.

Authors:  Yury I Miller; Suganya Viriyakosol; Christoph J Binder; James R Feramisco; Theo N Kirkland; Joseph L Witztum
Journal:  J Biol Chem       Date:  2002-11-06       Impact factor: 5.157

8.  Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.

Authors:  A Faggiotto; R Ross; L Harker
Journal:  Arteriosclerosis       Date:  1984 Jul-Aug

9.  The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

10.  Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways.

Authors:  Patrick G Arndt; Naohito Suzuki; Natalie J Avdi; Kenneth C Malcolm; G Scott Worthen
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  95 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

2.  Macrophages actively accumulate malonyldialdehyde-modified but not enzymatically oxidized low density lipoprotein.

Authors:  V Z Lankin; A K Tikhaze; E M Kumskova
Journal:  Mol Cell Biochem       Date:  2012-02-04       Impact factor: 3.396

Review 3.  The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL.

Authors:  Yury I Miller; Soo-Ho Choi; Philipp Wiesner; Yun Soo Bae
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 4.  Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis.

Authors:  Sasha A Doodnauth; Sergio Grinstein; Michelle E Maxson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

5.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

Review 6.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 7.  Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

Authors:  Adam Taleb; Joseph L Witztum; Sotirios Tsimikas
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

8.  Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.

Authors:  Calvin Yeang; Devin Hasanally; Xuchu Que; Ming-Yow Hung; Aleksandra Stamenkovic; David Chan; Rakesh Chaudhary; Victoria Margulets; Andrea L Edel; Masahiko Hoshijima; Yusu Gu; William Bradford; Nancy Dalton; Phuong Miu; David Yc Cheung; Davinder S Jassal; Grant N Pierce; Kirk L Peterson; Lorrie A Kirshenbaum; Joseph L Witztum; Sotirios Tsimikas; Amir Ravandi
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

Review 9.  Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis.

Authors:  Longhou Fang; Chao Liu; Yury I Miller
Journal:  Transl Res       Date:  2013-10-02       Impact factor: 7.012

Review 10.  Emerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipids.

Authors:  Longhou Fang; Yury I Miller
Journal:  Free Radic Biol Med       Date:  2012-08-11       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.